• Colorectal Cancer Info MAIN MENU
  • Screening & Prevention MAIN MENU
  • Patient & Family Support MAIN MENU
  • Get Involved MAIN MENU
  • Funding Research MAIN MENU
  • Our Mission MAIN MENU

Subscribe to the Newsletter

The Colon Cancer Alliance applauds the final report from the U. S. Preventive Services Task Force (USPSTF) on screening for colorectal cancer.

First and foremost, the USPSTF has maintained its “A” grade to screening for colorectal cancer; recognizing the high level of certainty that screening reduces colorectal cancer mortality and recommending that adults between the ages of 50 and 75 get timely screening.

Secondly, the final report resolves the concerns we expressed regarding several items in the initial draft report, including labeling some screening methods as “recommended” and others as “alternative.”

We specifically named these tests in our concerns as a major barrier to screening for Americans, and we applaud the USPSTF for widening its inclusion for these newer and proven tests.

“Screening saves lives. Newer screening methods like the Cologuard Stool DNA test and virtual colonography are redefining the future of cancer screening for Americans that are unable or unwilling to get a colonoscopy. By changing their recommendations to include these newer tests, the USPSTF has opened the door for countless more Americans to get screened,” says Michael Sapienza, Chief Executive Officer of the Colon Cancer Alliance. “We thank the USPSTF for taking our input seriously and accepting our suggestions.”

The Task Force clarified its recommendations to better communicate the importance of the lifesaving benefits of screening for colorectal cancer and that there is not a “one-size fits all” approach to screening. We commend the Task Force for the proactive way in which it engaged and responded to the colorectal cancer community regarding the draft report.

 “I would like to recognize Eric Hargis, Senior Policy Adviser at the Colon Cancer Alliance, for his hard work on this issue,” continued Sapienza. “His leadership has set a new standard for patient advocacy, and his guidance continues to advance our mission and the message that colorectal cancer screening saves lives.”

The Colon Cancer Alliance serves as a leading patient advocacy group and a source of information about colon health. If you have questions or are in need of support, please contact our free Helpline at (877) 422-2030. We’re here to help!

Categories:

Related reading